Oronazol

Oronazol may be available in the countries listed below.

Ingredient matches for Oronazol

Ketoconazole

Ketoconazole is reported as an ingredient of Oronazol in the following countries:

• Bosnia & Herzegowina


• Croatia (Hrvatska)


• Estonia


• Georgia


• Latvia


• Lithuania


• Slovenia

International Drug Name Search

Easium

Easium may be available in the countries listed below.

Ingredient matches for Easium

Diazepam

Diazepam is reported as an ingredient of Easium in the following countries:

• Bangladesh

International Drug Name Search

Choline Salicylate

In the US, Choline Salicylate is a member of the drug class salicylates.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N02BA03

CAS registry number (Chemical Abstracts Service)

0002016-36-6

Chemical Formula

C12-H19-N-O4

Molecular Weight

241

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Chemical Name

Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 2-hydroxybenzoic acid (1:1)

Foreign Names

• Cholini Salicylas (Latin)
• Cholin salicylat (German)
• Salicylate de Choline (French)
• Salicilato de colina (Spanish)

Generic Names

• Choline Salicylate (OS: USAN, BAN)
• Choline Salicylate Solution (PH: BP 2010)
• Choline Magnesium Trisalicylate (IS)

Brand Names

• Audax
  Norpharma, Iceland; SSL, Ireland



• Bonjela
  Reckitt Benckiser, New Zealand



• Bonjela (Choline Salicylate and Cetalkonium Chloride)
  Reckitt Benckiser, South Africa



• Cholinex
  GlaxoSmithKline, Poland; GlaxoSmithKline, Romania



• Faringodol
  GlaxoSmithKline, Estonia; GlaxoSmithKline, Lithuania



• Herron Baby Teething Gel
  Herron, Australia



• Larydol
  GlaxoSmithKline, Latvia



• Mundisal
  Char Deh, Taiwan; Mundipharma, Austria; Mundipharma, Switzerland; Mundipharma, Czech Republic; Mundipharma, Lithuania; Mundipharma, Latvia; Mundipharma, Slovakia



• Mundisal (Choline Salicylate and Cetalkonium Chloride)
  Lavipharm, Greece



• Ora Sed Gel (Choline Salicylate and Benzalkonium)
  Johnson & Johnson, New Zealand



• Ora-Sed
  Pfizer, Hong Kong



• Otinum
  ICN, Georgia; ICN, Lithuania; ICN, Latvia; ICN, Poland; Valeant, Russian Federation



• Ototalgin
  Farmina, Poland



• Pansoral
  Unimed, Tunisia



• Pansoral (Choline Salicylate and Cetalkonium Chloride)
  Pierre Fabre, Switzerland; Pierre Fabre Médicament, France



• Sachol (Choline Salicylate and Cetalkonium Chloride)
  Jelfa, Poland



• Teejel (Choline Salicylate and Cetalkonium Chloride)
  Adcock Ingram Pharmaceuticals, South Africa; Meda, Belgium; Meda, Luxembourg; SSL, Ireland



• Tricosal
  Qualitest, United States; Vintage, United States



• Trilisate
  Purdue Pharma, United States

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Eritromicina Medifarma

Eritromicina Medifarma may be available in the countries listed below.

Ingredient matches for Eritromicina Medifarma

Erythromycin

Erythromycin is reported as an ingredient of Eritromicina Medifarma in the following countries:

• Peru

International Drug Name Search

Thalassemia Medications

There are currently no drugs listed for "Thalassemia".

Definition of Thalassemia: Thalassemias are hereditary disorders characterized by defective production of hemoglobin. This leads to low production, and over destruction, of red blood cells. More...

Learn more about Thalassemia

Micromedex Care Notes:

• Hemolytic Anemia

Medical Encyclopedia:

• Thalassemia

Drug List:

Sumatriptan Hexal

Sumatriptan Hexal may be available in the countries listed below.

Ingredient matches for Sumatriptan Hexal

Sumatriptan

Sumatriptan is reported as an ingredient of Sumatriptan Hexal in the following countries:

• Luxembourg

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sumatriptan Hexal in the following countries:

• Austria


• Denmark


• Germany

International Drug Name Search

Oruvail Extended-Release Capsules

Pronunciation: KEE-toe-PROE-fen
Generic Name: Ketoprofen
Brand Name: Oruvail

Oruvail Extended-Release Capsules are a nonsteroidal anti-inflammatory drug (NSAID). It may cause an increased risk of serious and sometimes fatal heart and blood vessel problems (eg, heart attack, stroke). The risk may be greater if you already have heart problems or if you take Oruvail Extended-Release Capsules for a long time. Do not use Oruvail Extended-Release Capsules right before or after bypass heart surgery.

Oruvail Extended-Release Capsules may cause an increased risk of serious and sometimes fatal stomach ulcers and bleeding. Elderly patients may be at greater risk. This may occur without warning signs.

Oruvail Extended-Release Capsules are used for:

Treating rheumatoid arthritis or osteoarthritis. It is also used to treat menstrual cramps and pain. It may also be used for other conditions as determined by your doctor.

Oruvail Extended-Release Capsules are an NSAID. Exactly how it works is not known. It may block certain substances in the body that are linked to inflammation. NSAIDs treat the symptoms of pain and inflammation. They do not treat the disease that causes those symptoms.

Do NOT use Oruvail Extended-Release Capsules if:

• you are allergic to any ingredient in Oruvail Extended-Release Capsules


• you have had a severe allergic reaction (eg, severe rash, hives, trouble breathing, growths in the nose, dizziness) to aspirin or an NSAID (eg, ibuprofen, celecoxib)


• you have recently had or will be having bypass heart surgery


• you are also taking probenecid


• you are in the last 3 months of pregnancy

Contact your doctor or health care provider right away if any of these apply to you.

Before using Oruvail Extended-Release Capsules:

Some medical conditions may interact with Oruvail Extended-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal product, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of kidney or liver disease, diabetes, or stomach or bowel problems (eg, bleeding, perforation, ulcers)


• if you have a history of swelling or fluid buildup, asthma, growths in the nose (nasal polyps), or mouth inflammation


• if you have high blood pressure, blood disorders (eg, low blood albumin levels), bleeding or clotting problems, heart problems (eg, heart failure), or blood vessel disease, or if you are at risk for any of these diseases


• if you have poor health, dehydration or low fluid volume, or low blood sodium levels, you drink alcohol, or you have a history of alcohol abuse

Some MEDICINES MAY INTERACT with Oruvail Extended-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin), aspirin, corticosteroids (eg, prednisone), heparin, or selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) because risk of stomach bleeding may be increased


• Probenecid because it may increase the risk of Oruvail Extended-Release Capsules's side effects


• Cyclosporine, lithium, methotrexate, quinolones (eg, ciprofloxacin), or sulfonylureas (eg, glipizide) because the risk of their side effects may be increased by Oruvail Extended-Release Capsules


• Angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril) or diuretics (eg, furosemide, hydrochlorothiazide) because their effectiveness may be decreased by Oruvail Extended-Release Capsules

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oruvail Extended-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Oruvail Extended-Release Capsules:

Use Oruvail Extended-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Oruvail Extended-Release Capsules comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Oruvail Extended-Release Capsules refilled.


• Take Oruvail Extended-Release Capsules by mouth. It may be taken with food if it upsets your stomach. Taking it with food may not lower the risk of stomach or bowel problems (eg, bleeding, ulcers). Talk with your doctor or pharmacist if you have persistent stomach upset.


• Swallow Oruvail Extended-Release Capsules whole. Do not break, crush, or chew before swallowing.


• Take Oruvail Extended-Release Capsules with a full glass of water (8 oz/240 mL) as directed by your doctor.


• If you miss a dose of Oruvail Extended-Release Capsules and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose. Go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about the proper use of Oruvail Extended-Release Capsules.

Important safety information:

• Oruvail Extended-Release Capsules may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Oruvail Extended-Release Capsules with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Serious stomach ulcers or bleeding can occur with the use of Oruvail Extended-Release Capsules. Taking it in high doses, for a long time, smoking, or drinking alcohol increases the risk of these side effects. Taking Oruvail Extended-Release Capsules with food will NOT reduce the risk of these effects. If you have severe stomach or back pain; black, tarry stools; vomit that looks like blood or coffee grounds; or unusual weight gain or swelling, contact your doctor or emergency room right away.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Oruvail Extended-Release Capsules are an NSAID. Before you start any new medicine, check the label to see if it has an NSAID (eg, ibuprofen) in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do not take aspirin while you are using Oruvail Extended-Release Capsules unless your doctor tells you to.


• Lab tests, including kidney function, complete blood cell counts, and blood pressure, may be performed while you use Oruvail Extended-Release Capsules. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Oruvail Extended-Release Capsules with caution in the ELDERLY; they may be more sensitive to its effects, especially stomach bleeding and kidney problems.


• Oruvail Extended-Release Capsules should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Oruvail Extended-Release Capsules may cause harm to the fetus. Do not use it during the last 3 months of pregnancy. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Oruvail Extended-Release Capsules while you are pregnant. It is not known if Oruvail Extended-Release Capsules are found in breast milk. Do not breast-feed while taking Oruvail Extended-Release Capsules.

Possible side effects of Oruvail Extended-Release Capsules:

All medicines can cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; gas; headache; heartburn; nausea; stomach upset.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; trouble breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody or black tarry stools; change in the amount of urine produced; chest pain; confusion; dark urine; depression; fainting; fast or irregular heartbeat; fever, chills, or persistent sore throat; mental or mood changes; numbness of an arm or leg; one-sided weakness; red, swollen, blistered, or peeling skin; ringing in the ears; seizures; severe headache or dizziness; severe or persistent stomach pain or nausea; severe vomiting; shortness of breath; sudden or unexplained weight gain; swelling of hands, legs, or feet; unusual bruising or bleeding; unusual joint or muscle pain; unusual tiredness or weakness; vision or speech changes; vomit that looks like coffee grounds; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Oruvail side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include decreased urination; loss of consciousness; seizures; severe dizziness or drowsiness; severe nausea or stomach pain; slow or troubled breathing; tremor; unusual bleeding or bruising; vomit that looks like coffee grounds.

Proper storage of Oruvail Extended-Release Capsules:

Store Oruvail Extended-Release Capsules at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oruvail Extended-Release Capsules out of the reach of children and away from pets.

General information:

• If you have any questions about Oruvail Extended-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.


• Oruvail Extended-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Oruvail Extended-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Oruvail resources

• Oruvail Side Effects (in more detail)
• Oruvail Use in Pregnancy & Breastfeeding
• Drug Images
• Oruvail Drug Interactions
• Oruvail Support Group
• 0 Reviews for Oruvail - Add your own review/rating

Compare Oruvail with other medications

• Back Pain
• Fever
• Frozen Shoulder
• Gout, Acute
• Osteoarthritis
• Pain
• Period Pain
• Rheumatoid Arthritis
• Sciatica

Corulon

Corulon may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Corulon

Chorionic Gonadotrophin

Chorionic Gonadotrophin is reported as an ingredient of Corulon in the following countries:

• Italy

International Drug Name Search

Kaptoril

Kaptoril may be available in the countries listed below.

Ingredient matches for Kaptoril

Captopril

Captopril is reported as an ingredient of Kaptoril in the following countries:

• Turkey

International Drug Name Search